These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 11160775

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Calcimimetics normalize the phosphate-induced stimulation of PTH secretion in vivo and in vitro.
    Almaden Y, Rodriguez-Ortiz ME, Canalejo A, Cañadillas S, Canalejo R, Martin D, Aguilera-Tejero E, Rodríguez M.
    J Nephrol; 2009; 22(2):281-8. PubMed ID: 19384847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Calcimimmetic and calcilytics: new perspectives of correction of abnormal parathormone (PTH) secretion].
    Rybczyńska A, Hoppe A.
    Przegl Lek; 2003; 60(6):418-24. PubMed ID: 14974181
    [Abstract] [Full Text] [Related]

  • 9. [Calcimimetics, mechanisms of action and therapeutic applications].
    Ureña P, Legoupil N, de Vernejoul MC.
    Presse Med; 2005 Sep 10; 34(15):1095-100. PubMed ID: 16334889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
    Nagano N, Nemeth EF.
    J Pharmacol Sci; 2005 Mar 10; 97(3):355-60. PubMed ID: 15781990
    [Abstract] [Full Text] [Related]

  • 12. Calcimimetics and hyperparathyroidism.
    Krebs LJ.
    Curr Opin Investig Drugs; 2004 Oct 10; 5(10):1080-5. PubMed ID: 15535429
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The calcium receptor and calcimimetics.
    Wada M, Nagano N, Nemeth EF.
    Curr Opin Nephrol Hypertens; 1999 Jul 10; 8(4):429-33. PubMed ID: 10491737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication.
    Antonsen JE, Sherrard DJ, Andress DL.
    Kidney Int; 1998 Jan 10; 53(1):223-7. PubMed ID: 9453023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.